切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (06) : 613 -616. doi: 10.3877/cma.j.issn.1674-3946.2021.06.008

论著

保留乳头乳晕复合体乳房切除术中三种乳房重建术的临床效果对比
宋海涛1, 马斌1(), 杨乐1, 董朝1, 马斌林1,()   
  1. 1. 830011 新疆医科大学附属肿瘤医院乳腺甲状腺外科
  • 收稿日期:2020-09-16 出版日期:2021-12-26
  • 通信作者: 马斌, 马斌林

Comparison of clinical effects of three kinds of breast reconstruction in nipple-preserving areola complex mastectomy

Haitao Song1, Bin Ma1,(), Le Yang1, Chao Dong1, Binlin Ma1()   

  1. 1. Affiliated Cancer Hospital of Xinjiang Medical University Breast Thyroid Surgery, Wulumuqi 830011, China
  • Received:2020-09-16 Published:2021-12-26
  • Corresponding author: Bin Ma, Binlin Ma
  • Supported by:
    Natural Science Fund of Xinjiang Uygur Autonomous Region(2020D01C203)
引用本文:

宋海涛, 马斌, 杨乐, 董朝, 马斌林. 保留乳头乳晕复合体乳房切除术中三种乳房重建术的临床效果对比[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(06): 613-616.

Haitao Song, Bin Ma, Le Yang, Chao Dong, Binlin Ma. Comparison of clinical effects of three kinds of breast reconstruction in nipple-preserving areola complex mastectomy[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(06): 613-616.

目的

探讨三种即刻乳房重建术在保留乳头乳晕复合体乳房切除术(NSM)的临床疗效。

方法

回顾性分析2017年1月至2019年12月乳房重建的131例NSM患者临床资料,根据乳房重建方式不同分为三组,假体组(n=56,假体植入),自体组(n=43,背阔肌皮瓣植入),联合组(n=32,背阔肌联合假体植入)。采用SPSS 21.00软件进行数据分析,围术期指标等计量资料采用(±s)表示,多组间比较采用单因素方差分析;术后并发症等计数资料采用χ2检验,等级计数资料采用秩和检验;Kaplan-Meier法分析预后总生存率(OS)和无病生存率(DFS)。P<0.05为差异有统计学意义。

结果

三组术中出血量、引流总流量、住院时间、术后并发症总发生率比较差异均无统计学意义(P>0.05);自体组和联合组总优良率均显著高于假体组(P<0.05),但这两组总优良率差异无统计学意义(P>0.05);三组患者DFS、OS比较差异无统计学意义(P>0.05)。

结论

NSM的三种即刻乳房重建术均安全有效,其中采用背阔肌皮瓣或其联合假体进行乳房重建术的美容效果更佳,临床可根据患者个人意愿及生理条件选择合适的乳房重建术式。

Objective

To investigate the clinical effect of three types of immediate breast reconstruction in nipple and areola complex mastectomy (NSM).

Methods

The clinical data of 131 NSM patients undergoing breast reconstruction from January 2017 to December 2019 were retrospectively analyzed. According to different breast reconstruction methods, the patients were divided into three groups: prosthesis group (n=56, prosthesis implantation), autogenous group (n=43, latissimus dorsi flap implantation), and combined group (n=32, latissimus dorsi combined prosthesis implantation). Using SPSS 21.00 software for data analysis, perioperative indicators such as measurement data using (±s) said, compared using analysis of variance between groups; Postoperative complication rate and other data were counted by χ2 test.The beauty effect was evaluated by rank sum test. Overall survival (OS) and disease-free survival (DFS) were analyzed by Kaplan-Meier method. P<0.05 was statistically significant.

Results

There were no statistically significant differences in the perioperative indexes such as intraoperative blood loss and total drainage flow among the three groups (P>0.05); there was no statistically significant difference in the total incidence of complications among the three groups (P>0.05); autologous group and combined. The overall excellent and good rate of the group was significantly higher than that of the prosthetic group, the difference was statistically significant (P<0.05), but the total excellent and good rate of the autologous group and the combined group was not statistically different (P>0.05); There was no significant difference in DFS and OS among the three groups (P>0.05).

Conclusion

Three kinds of immediate breast reconstruction with NSM are safe and effective. The latissimus dorsi flap or its combined prosthesis has better cosmetic effect. The appropriate breast reconstruction operation can be selected according to the individual wishes and physiological conditions of patients.

表1 131例NSM患者不同术式三组患者一般资料对比[(±s),例]
表2 131例NSM患者不同术式三组患者围术期指标比较(±s)
表3 131例NSM患者不同术式三组患者并发症发生比较(例)
表4 131例NSM患者不同术式三组患者美容效果比较(例)
图2 131例NSM患者不同术式三组三组患者OS比较
[1]
Chen WQ, Zheng RS, Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin201666(2):115-132.
[2]
Huang NS, Liu MY, Chen JJ, et al. Surgical management of breast cancer in China: a 15-year single-center retrospective study of 18,502 patients[J]. Medicine (Baltimore), 2016, 95(45):e4201.
[3]
刘峥,杨基鹏,任思媛,等.保留乳头的乳腺癌切除术在早期乳腺癌患者中临床效果研究[J].中华普外科手术学杂志(电子版)202014(03):273-276.
[4]
潘梦婷,孟爱凤,智晓旭,等.心理干预对乳腺癌根治术后乳房缺失患者生活质量影响的meta分析[J].护理实践与研究201714(22):1-6.
[5]
中国抗癌协会乳腺癌专业委员会,中国医师协会外科医师分会乳腺外科医师专委会,吴炅,等.乳腺肿瘤整形与乳房重建专家共识( 2018年版) [J].中国癌症杂志201828( 6) :439-480.
[6]
王文尖,覃世运,陈丽君.低分割放射治疗对早期乳腺癌保留乳房手术后患者的疗效和安全性评价[J/CD].中华乳腺病杂志(电子版)201711(4):213-217.
[7]
陈海军,翟保平,贾琳娇,等.乳腺癌术后Ⅰ期假体植入乳房重建术后使用抗生素与术后假体乳房感染的研究[J].中华普外科手术学杂志(电子版)201913(02):159-161.
[8]
蓝洪波.乳腺癌术后即刻背阔肌皮瓣乳房重建术的研究进展[J].广西医学201739(4):523-526.
[9]
吴永芳,殷国前.硅凝胶假体隆乳术后并发症的防治进展[J].中国医药指南201816(18):46-47.
[10]
Pu Y, Mao TC, Zhang YM,et al.The role of postmastectomy radiation therapy in patients with immediate prosthetic breast reconstruction: A meta-analysis[J].Medicine( Baltimore)201897(6): e9548.
[11]
Bertozzi N, Pesce M, Santi P,et al.Tissue expansion for breast recon struction: Methods and techniques[J].Ann Med Surg(Lond)201721: 34-44.
[12]
夏想厚,俞洋,扬红健.保留乳头乳晕乳房切除-重建术研究进展[J/CD].中华乳腺病杂志(电子版)201610(4):243-246.
[13]
Maalouf C, Bou-Merhi J, Karam E,et al.The impact to fautologous breast reconstruction using DIEP flap on the oncologic efficacy of radiation the rapy [J].Ann Chir Plast Esthet201762(6):630-636.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要